Inactive Instrument
Sector dividends Plasmatech Biopharmaceuticals Inc Nasdaq
Stocks
US72754H1095
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 29/06 | Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark | CI |
| 29/06 | Abeona Therapeutics Inc.(NasdaqCM:ABEO) added to Russell 2000 Value-Defensive Index | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.51% | 0.58% | 18.09x | 2.32x | 4.1x | 9.64x | 11.26x | 7.62TCr | ||
| 0.69% | 0.72% | 22.85x | 3.46x | 4.95x | 14.41x | 17.47x | 4.89TCr | ||
| -.--% | -.--% | 36.16x | 7.44x | 12.36x | 23.52x | 27.52x | 4.78TCr | ||
| 3.29% | 3.38% | -46.27x | 2.57x | 3.25x | 9.61x | 11.21x | 4.14TCr | ||
| -.--% | -.--% | 37.23x | 1.65x | 3.36x | 12.07x | 13.84x | 3TCr | ||
| -.--% | -.--% | 55.01x | 4.08x | 3.36x | 26.05x | 23.16x | 2.42TCr | ||
| -.--% | -.--% | -6.33x | 4.31x | 8.83x | -5.56x | -5.23x | 2.19TCr | ||
| -.--% | 0.05% | 63.91x | 5.61x | 6.11x | 41.98x | 48.5x | 1.92TCr | ||
| -.--% | -.--% | 24.69x | 3.63x | 5.29x | 13.78x | 19.15x | 1.71TCr | ||
| -.--% | -.--% | -36x | -6.39x | 17.16x | -46.97x | -54.28x | 1.57TCr | ||
| -.--% | -.--% | 17.77x | - | 3.64x | 14.09x | 16.45x | 1.16TCr | ||
| 0.17% | 0.17% | 56.44x | 23.02x | 34.19x | 48.35x | 49.87x | 1.15TCr | ||
| -.--% | -.--% | -104.97x | 11546.08x | 11.34x | -81.23x | -112.11x | 1.12TCr | ||
| -.--% | -.--% | 46.54x | - | - | - | - | 1.01TCr | ||
| 2.76% | 3.01% | 12.69x | 1.17x | 1.89x | 7.64x | 10.3x | 684.02Cr | ||
| 0.35% | 0.41% | 29.58x | - | 7.98x | 21.16x | 25.28x | 605.62Cr | ||
| -.--% | -.--% | 58.9x | 7.08x | 5.73x | 31.69x | 42.68x | 580.03Cr | ||
| -.--% | -.--% | -116.26x | - | - | - | - | 572.78Cr | ||
| Average | 0.43% | 0.46% | 9.45x | 829.00x | 8.34x | 8.76x | 9.07x | 2.28TCr | |
| Weighted average by Cap. | 0.56% | 0.6% | 14.10x | 346.69x | 7.05x | 10.91x | 11.99x |
Select your edition
All financial news and data tailored to specific country editions
















